Predicting antiepileptic drug response in children with epilepsy

Matti Sillanpää1, Dieter Schmidt

  • 1Department of Public Health, University of Turku, Turku, Finland.

Insights

Predicting seizure remission in childhood epilepsy is crucial. Over 90% of idiopathic cases achieve remission, while complex epilepsies have lower remission rates, impacting treatment strategies.

Area of Science:

  • Pediatric Neurology
  • Clinical Epilepsy Research

Background:

  • Accurate prediction of seizure remission in childhood epilepsy is vital for effective clinical management.
  • Identifying factors that predict seizure freedom or medically intractable seizures guides treatment decisions.

Purpose of the Study:

  • To summarize key factors that predict seizure remission in children with epilepsy treated with antiepileptic drugs (AEDs).
  • To provide insights into expected remission rates based on epilepsy type and clinical presentation.

Main Methods:

  • Review and synthesis of existing literature on factors influencing seizure remission in childhood-onset epilepsy.
  • Analysis of remission rates based on epilepsy etiology, seizure characteristics, and treatment response.

Main Results:

  • Sustained seizure remission is expected in over 90% of idiopathic childhood epilepsies and in neurologically normal children with infrequent seizures showing early treatment response.
  • Even with symptomatic epilepsy, focal seizures, high frequency, clustering, or delayed response to initial therapy, up to 60% may achieve long-term remission.
  • Remission rates are significantly lower, 30% or less, in catastrophic epilepsies of childhood.

Conclusions:

  • Prognosis for seizure remission varies widely based on epilepsy classification and clinical features in children.
  • Early identification of predictive factors can optimize therapeutic strategies and improve outcomes for children with epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...